Psychemedics Corp PMD
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if PMD is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $2.65
- Day Range
- $2.61–2.64
- 52-Week Range
- $2.06–5.59
- Bid/Ask
- $2.57 / $2.64
- Market Cap
- $15.33 Mil
- Volume/Avg
- 1,103 / 8,979
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.69
- Dividend Yield (Trailing)
- 5.41%
- Dividend Yield (Forward)
- 10.83%
- Total Yield
- 5.41%
Company Profile
Psychemedics Corp is engaged in providing testing services for the detection of drugs of abuse through the analysis of hair samples. The company operates through a single segment of drug testing services which include training for the collection of samples and storage of positive samples for its customers for an agreed-upon fee per unit testing of samples. The testing methods of the company utilize a patented technology that digests the hair and releases drugs trapped in the hair without destroying the drugs. They provide testing services for the detection of drugs of abuse and other health markers through the analysis of hair samples. Geographically it generates the majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Diagnostics & Research
- Stock Style Box
- Small Value
- Total Number of Employees
- 116
- Website
- https://www.psychemedics.com
Valuation
|
Metric
|
PMD
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.31 |
Price/Sales | 0.69 |
Price/Cash Flow | 61.95 |
Price/Earnings
PMD
Financial Strength
|
Metric
|
PMD
|
|---|---|
Quick Ratio | 1.20 |
Current Ratio | 1.45 |
Interest Coverage | −201.24 |
Quick Ratio
PMD
Profitability
|
Metric
|
PMD
|
|---|---|
Return on Assets (Normalized) | −18.45% |
Return on Equity (Normalized) | −33.20% |
Return on Invested Capital (Normalized) | −24.74% |
Return on Assets
PMD
Diagnostics & Research Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
TMO
| Thermo Fisher Scientific Inc | Bxwdzqcqyw | Wmc | $209.3 Bil | |
DHR
| Danaher Corp | Rnscdyhlb | Vmrkcc | $185.5 Bil | |
IQV
| IQVIA Holdings Inc | Shvfkwpf | Ygplxhh | $43.4 Bil | |
IDXX
| IDEXX Laboratories Inc | Rhswlfbsw | Wpskvy | $41.0 Bil | |
A
| Agilent Technologies Inc | Cdpvbcbt | Tsq | $40.3 Bil | |
MTD
| Mettler-Toledo International Inc | Zfdksxcln | Ksybbd | $26.4 Bil | |
ICLR
| Icon PLC | Hpkxfzy | Bwtgvt | $25.2 Bil | |
ILMN
| Illumina Inc | Njbbjqf | Fkdyqr | $19.6 Bil | |
WAT
| Waters Corp | Dcvjcmft | Bvrwc | $18.0 Bil | |
LH
| Laboratory Corp of America Holdings | Wntbbvln | Xthzvx | $17.5 Bil |